How have CHB shares performed in 2024?

Global X China Biotech Innovation ETF's stock was trading at $8.10 on January 1st, 2024. Since then, CHB shares have decreased by 18.0% and is now trading at $6.64. View the best growth stocks for 2024 here .

How often does Global X China Biotech Innovation ETF pay dividends? What is the dividend yield for Global X China Biotech Innovation ETF?

Global X China Biotech Innovation ETF announced a Semi-Annual dividend on Wednesday, December 27th. Investors of record on Friday, December 29th will be paid a dividend of $0.002 per share on Monday, January 8th. The ex-dividend date is Thursday, December 28th. Read our dividend analysis for CHB .

What does CHB invest in?

Global X China Biotech Innovation ETF is a equity fund issued by Global X. CHB focuses on theme investments and follows the Solactive China Biotech Innovation Index. The fund's investments total to approximately $1.41 million assets under management.

What is the management fee for Global X China Biotech Innovation ETF?

Global X China Biotech Innovation ETF's management fee is 0.65% and has other expenses of 0.02%. The net expense ratio for CHB is 0.67%.

How do I buy shares of Global X China Biotech Innovation ETF?

Shares of CHB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NASDAQ:CHB

Global X China Biotech Innovation ETF (CHB) Price, Holdings, & News

→ Did You Get Your Free Bitcoin Yet? (From Crypto Swap Profits) (Ad)

Free CHB Stock Alerts

$6.64

0.00 (0.00%)

(As of 02/26/2024)

Compare

Today's Range: $6.64
▼
$6.64
50-Day Range: $6.64
▼
$6.67
52-Week Range: $6.63
▼
$10.07

Volume: N/A
Average Volume: 712 shs
Market Capitalization: $1.39 million

Assets Under Management: $1.41 million
Dividend Yield: 0.45%
Net Expense Ratio: 0.67%

Stock Analysis Chart Dividend Headlines Holdings Ratings Short Interest Social Media

Get Global X China Biotech Innovation ETF alerts:

About Global X China Biotech Innovation ETF (NASDAQ:CHB)

The Global X China Biotech Innovation ETF (CHB) is an exchange-traded fund that is based on the Solactive China Biotech Innovation index. The fund tracks a market-cap weighted index of Chinese companies that are involved in the biotechnology industry. CHB was launched on Sep 22, 2020 and is managed by Global X.

CHB Stock Price History

30 days | 90 days | 365 days | Advanced Chart

CHB ETF News Headlines

February 26, 2024 | investing.com

Global X China Electric Vehicle and Battery ETF (9845)

December 29, 2023 | msn.com

Global X China Biotech Innovation ETF declares semi-annual distribution of $0.0019

April 18, 2024 | Crypto Swap Profits (Ad)

Did You Get Your Free Bitcoin Yet?

And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.

December 4, 2023 | wsj.com

This Chinese Biotech Stock Just Fell 24%

November 18, 2023 | investing.com

CHIE ETF Stock Price History

September 26, 2023 | benzinga.com

Biotechnology Contract Manufacturing Market worth $24.8 billion | MarketsandMarkets

September 8, 2023 | benzinga.com

CGTN: China's northeast region to advance revitalization via tech innovation

August 21, 2023 | wsj.com

Beijing Bohui Innovation Biotechnology Group Co. Ltd. A

April 18, 2024 | Crypto Swap Profits (Ad)

Did You Get Your Free Bitcoin Yet?

July 28, 2023 | investing.com

Global X China Biotech USD (9820)

See More Headlines

Receive CHB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Global X China Biotech Innovation ETF and its competitors with MarketBeat's FREE daily newsletter.

Fund Details

Issuer: Global X
Fund Name: Global X China Biotech Innovation ETF
Tax Classification: Regulated Investment Company
Stock Exchange: NASDAQ
Current Symbol: NASDAQ:CHB
Inception Date: 9/22/2020
Fund Manager: Chang Kim, Nam To, Wayne Xie, Kimberly Chan
Web: N/A
Phone: N/A

Fund Focus

Asset Class: Equity
Benchmark: Solactive China Biotech Innovation Index
Category: Strategy
Focus: Theme
Development Level: Emerging Markets
Region: Asia-Pacific
Number of Holdings: 2

Fund Statistics

Assets Under Management: $1.41 million
Average Daily Volume: $0.00
Discount/Premium: -0.07%

Administrator, Advisor and Custodian

Administrator: Global X Management Company LLC
Advisor: Global X Management Company LLC
Custodian: Brown Brothers Harriman & Co.
Distributor: SEI Investments Distribution Co.
Transfer Agent: Brown Brothers Harriman & Co.
Trustee: N/A
Lead Market Maker: Susquehanna

Options

Optionable: N/A
Short Interest: 8,800 shs

Miscellaneous

Outstanding Shares: 210,000
Beta: 0.29
Creation Unit: 50,000
Creation Fee: $600.00

Ten Starter Stocks For Beginners to Buy Now

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Ad Timothy Sykes

Urgent alert: open this for a huge profit potential

This groundbreaking technology that Tim calls “Inception” isn’t being talked about anywhere… not on Fox, Yahoo, or CNBC.

See Tim’s instructions to make this remarkably simple trade right here

Global X China Biotech Innovation ETF Expenses

Type	CHB	Theme ETFs	Equity ETFs	NASDAQ ETFs	All ETFs
Management Fee	0.65%	0.57%	0.54%	0.48%	0.51%
Other Expenses	0.02%	0.71%	0.54%	0.34%	0.58%
Total Expense	0.67%	0.72%	0.70%	0.58%	0.70%
Fee Waiver	0.00%	-0.76%	-0.55%	-0.22%	-0.57%
Net Expense	0.67%	0.59%	0.60%	0.54%	0.58%

Global X China Biotech Innovation ETF (CHB) Holdings

Top 10 CHB Holdings

WuXi Biologics (Cayman) Inc
Holding Weight: 8.87%
Changchun High and New Technology Industry Group Inc Class A
Holding Weight: 7.91%
Chongqing Zhifei Biological Products Co Ltd Class A
Holding Weight: 7.71%
Walvax Biotechnology Co Ltd Class A
Holding Weight: 7.60%
CSPC Pharmaceutical Group Ltd
Holding Weight: 7.18%
Shanghai RAAS Blood Products Co Ltd Class A
Holding Weight: 4.94%
Beijing Tiantan Biological Products Corp Ltd Class A
Holding Weight: 4.76%
Hualan Biological Engineering Inc Class A
Holding Weight: 4.58%
Sichuan Kelun Pharmaceutical Co Ltd Class A
Holding Weight: 4.33%
Zai Lab(NASDAQ:ZLAB)
Holding Weight: 4.11%

Full Holdings Details

Similar ETFs

CHB ETF - Frequently Asked Questions

How have CHB shares performed in 2024?: Global X China Biotech Innovation ETF's stock was trading at $8.10 on January 1st, 2024. Since then, CHB shares have decreased by 18.0% and is now trading at $6.64.
View the best growth stocks for 2024 here.
How often does Global X China Biotech Innovation ETF pay dividends? What is the dividend yield for Global X China Biotech Innovation ETF?: Global X China Biotech Innovation ETF announced a Semi-Annual dividend on Wednesday, December 27th. Investors of record on Friday, December 29th will be paid a dividend of $0.002 per share on Monday, January 8th. The ex-dividend date is Thursday, December 28th.
Read our dividend analysis for CHB.
What does CHB invest in?: Global X China Biotech Innovation ETF is a equity fund issued by Global X. CHB focuses on theme investments and follows the Solactive China Biotech Innovation Index. The fund's investments total to approximately $1.41 million assets under management.

What is the management fee for Global X China Biotech Innovation ETF?: Global X China Biotech Innovation ETF's management fee is 0.65% and has other expenses of 0.02%. The net expense ratio for CHB is 0.67%.
How do I buy shares of Global X China Biotech Innovation ETF?: Shares of CHB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:CHB) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial